Treatment with let-7b rescues cisplatin sensitivity of cisplatin-resistant glioma cells by binding to CCND1 mRNA 3′ UTR to decrease CCND1 expression, which increases caspase 3 activity, apoptosis, and G1 phase cell count [67]. This evidence concerns the gene CCND1 and central nervous system cancer.